论文信息 - Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction - 字舞流文

Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction

A. Matucci | E. Maggi | A. Vultaggio | F. Nencini | S. Pratesi

[1] A. Matucci,et al. Acute infusion reactions induced by monoclonal antibody therapy , 2011, Expert review of clinical immunology.

[2] A. Matucci,et al. Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactions , 2010, Allergy.

[3] R. Pontarolo,et al. Meta‐analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis , 2010, Pharmacotherapy.

[4] L. Aarden,et al. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement. , 2008, Current opinion in immunology.

[5] R. Solensky,et al. Drug allergy. , 2010, The Journal of allergy and clinical immunology.